Fulvestrant
- Level
- Commodity
- Parent
- 51351600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351609This classification denotes a selective estrogen receptor modulator with the molecular formula C32H47F5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22X328QOC4, chemically known as 7alpha-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol but generally known as fulvestrant, which bears US NIH Compound Identifier 104741. European Medicines Agency schedules Fulvestrant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13933MIG. The term FULVESTRANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules fulvestrant in its Anatomical Therapeutic Chemical (ATC) Classification. FULVESTRANT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fulvestrant under HS 29372300 and SITC 54153. As of Q4 2014, FULVESTRANT remains the US FDA Preferred Term for this commodity. Fulvestrant bears US NLM identifiers UMLS ID C0935916 and NCI Concept Code C1379. SMILES: S(=O)(CCCCCCCCCC1C2C3C(CCC2C2C(C1)CC(O)CC2)(C(O)CC3)C)CCCC(F)(F)C(F)(F)F.
Same parent
Under 51351600 · 35Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.